SGLT2 Inhibitors in Diabetic Patients With Cardiovascular Disease or at High Cardiovascular Risk: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

OBJECTIVE: To investigate the effect of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in patients with diabetes with cardiovascular disease (CVD) or at high cardiovascular risk. DESIGN: Systematic review and meta-analysis of randomized controlled trials (RCTs). DATA SOURCES: Pubmed, Embase, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zinan, Jin, Pengfei, Zhang, Yatong, Hu, Xin, Tian, Chao, Liu, Deping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087280/
https://www.ncbi.nlm.nih.gov/pubmed/35557542
http://dx.doi.org/10.3389/fcvm.2022.826684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087280/
https://www.ncbi.nlm.nih.gov/pubmed/35557542
http://dx.doi.org/10.3389/fcvm.2022.826684

Ejemplares similares